These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36033384)
1. Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors. Huang R; Zheng Y; Zou W; Liu C; Liu J; Yue J J Immunol Res; 2022; 2022():3781109. PubMed ID: 36033384 [TBL] [Abstract][Full Text] [Related]
2. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors. Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390 [TBL] [Abstract][Full Text] [Related]
5. Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation. Ren A; Li Z; Zhang X; Deng R; Ma Y J Hepatocell Carcinoma; 2020; 7():101-106. PubMed ID: 32766175 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy. Chen J; Huang W; Xu X; Fan S; Zhang Q; Li X; Zeng Z; He J Front Oncol; 2023; 13():1076428. PubMed ID: 37251953 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model]. Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796 [No Abstract] [Full Text] [Related]
8. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy. Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985 [No Abstract] [Full Text] [Related]
10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Schobert IT; Savic LJ; Chapiro J; Bousabarah K; Chen E; Laage-Gaupp F; Tefera J; Nezami N; Lin M; Pollak J; Schlachter T Eur Radiol; 2020 Oct; 30(10):5663-5673. PubMed ID: 32424595 [TBL] [Abstract][Full Text] [Related]
11. Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters. Jia G; Qiu L; Zheng H; Qin B; Sun Z; Shao Y; Yang Z; Shao J; Zhou Y; Jiao S BMC Cancer; 2023 Jun; 23(1):556. PubMed ID: 37328805 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy. Dharmapuri S; Ă–zbek U; Lin JY; Sung M; Schwartz M; Branch AD; Ang C Cancer Med; 2020 Jul; 9(14):4962-4970. PubMed ID: 32419290 [TBL] [Abstract][Full Text] [Related]
13. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria. Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257 [TBL] [Abstract][Full Text] [Related]
14. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. He CB; Lin XJ PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305 [TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization Combined With Radiofrequency Ablation. Yang XG; Huang YC; Wang CH; Sun YY; Huang Z; Xu GH Cancer Invest; 2022 Jul; 40(6):494-504. PubMed ID: 35404178 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients. Shi X; Li H; Xu Y; Nyalali AMK; Li F Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma. Lee JW; Hwang SH; Kim DY; Han KH; Yun M Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib. Pinto TAM; Saito HPA; Nourani CL; Ataide EC; Boin IFSF; Lourenco GJ; Lima CSP Gastroenterology Res; 2024 Feb; 17(1):23-31. PubMed ID: 38463146 [TBL] [Abstract][Full Text] [Related]
19. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy. Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy. Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]